Effect of METOprolol in CARDioproteCtioN During an Acute Myocardial InfarCtion. The METOCARD-CNIC Trial.
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 221 participants.
Also called NCT01311700
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 221 participants
- Sponsor
- Registry
-
NCT01311700 -
2010-019939-35
-
- Other papers using this trial's data
- Effect of Early Metoprolol During ST-Segment Elevation Myocardial Infarction on Left Ventricular Strain: Feature-Tracking Cardiovascular Magnetic Resonance Substudy From the METOCARD-CNIC Trial
- Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial
- Efficacy and safety of out-of-hospital intravenous metoprolol administration in anterior ST-segment elevation acute myocardial infarction: insights from the METOCARD-CNIC trial
- Left ventricular functional recovery of infarcted and remote myocardium after ST-segment elevation myocardial infarction (METOCARD-CNIC randomized clinical trial substudy)
- Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction)
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Spain
- Registry status
- Completed
Technical summary
Registry record NCT01311700. Randomized; single masking; primary purpose treatment. Start 2010-11 (registry gives no type); primary completion 2012-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of METOprolol in CARDioproteCtioN During an Acute Myocardial InfarCtion. The METOCARD-CNIC Trial.
- Acronym
- METOCARD-CNIC
- Condition
- Myocardial Infarction
- Intervention (Drug)
- Injectable (i.v.) metoprolol tartrate (up to 15 mg).
- Lead sponsor
- Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
- Collaborator
- Ministerio de Sanidad, Servicios Sociales e Igualdad
- Collaborator
- Fundación Mutua Madrileña
Record details
- Record id
cardio:ct-nct01311700- Content hash
763dbeaea2d44868db11624e40d2a0329ade1764f495ba396be6930cbf5f24a1